VERTEX PHARMACEUTICALS INC / MA Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Debt-to-equity for the quarter ending September 30, 2024 was 33.8 %, a 8.06% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 33.8 +2.52 +8.06% Sep 30, 2024
Q2 2024 31.3 +0.79 +2.59% Jun 30, 2024
Q1 2024 30.3 +0.05 +0.17% Mar 31, 2024
Q4 2023 30.9 +0.96 +3.21% Dec 31, 2023
Q3 2023 31.3 +0.81 +2.66% Sep 30, 2023
Q2 2023 30.5 -1.1 -3.48% Jun 30, 2023
Q1 2023 30.2 -1.99 -6.18% Mar 31, 2023
Q4 2022 30 -3.32 -9.98% Dec 31, 2022
Q3 2022 30.5 -3.36 -9.93% Sep 30, 2022
Q2 2022 31.6 -3.82 -10.8% Jun 30, 2022
Q1 2022 32.2 -4.01 -11.1% Mar 31, 2022
Q4 2021 33.3 -3.61 -9.79% Dec 31, 2021
Q3 2021 33.8 -3.51 -9.4% Sep 30, 2021
Q2 2021 35.4 -2.59 -6.82% Jun 30, 2021
Q1 2021 36.2 -2.66 -6.84% Mar 31, 2021
Q4 2020 36.9 Dec 31, 2020
Q3 2020 37.3 Sep 30, 2020
Q2 2020 38 Jun 30, 2020
Q1 2020 38.9 Mar 31, 2020
Q4 2018 53.4 -26.4 -33.1% Dec 31, 2018
Q3 2018 63.2 -28.9 -31.4% Sep 30, 2018
Q2 2018 67.8 -37.6 -35.7% Jun 30, 2018
Q1 2018 74 -46.3 -38.5% Mar 31, 2018
Q4 2017 79.8 -58.9 -42.5% Dec 31, 2017
Q3 2017 92.1 -50.4 -35.4% Sep 30, 2017
Q2 2017 105 -39.6 -27.3% Jun 30, 2017
Q1 2017 120 -26.7 -18.2% Mar 31, 2017
Q4 2016 139 -2.04 -1.45% Dec 31, 2016
Q3 2016 143 +11 +8.32% Sep 30, 2016
Q2 2016 145 +23.6 +19.4% Jun 30, 2016
Q1 2016 147 +41.9 +39.9% Mar 31, 2016
Q4 2015 141 +45.8 +48.3% Dec 31, 2015
Q3 2015 132 +47.7 +56.8% Sep 30, 2015
Q2 2015 121 +42.4 +53.7% Jun 30, 2015
Q1 2015 105 +26.6 +33.9% Mar 31, 2015
Q4 2014 95 -1.2 -1.25% Dec 31, 2014
Q3 2014 83.9 -33.2 -28.3% Sep 30, 2014
Q2 2014 79 -53.6 -40.4% Jun 30, 2014
Q1 2014 78.5 -72.6 -48% Mar 31, 2014
Q4 2013 96.2 -43.5 -31.2% Dec 31, 2013
Q3 2013 117 -22.9 -16.4% Sep 30, 2013
Q2 2013 133 -23.4 -15% Jun 30, 2013
Q1 2013 151 -46.9 -23.7% Mar 31, 2013
Q4 2012 140 Dec 31, 2012
Q3 2012 140 Sep 30, 2012
Q2 2012 156 Jun 30, 2012
Q1 2012 198 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.